Boston-based artificial intelligence (AI) assistant for healthcare professionals, Nabla, has secured $24 million in Series B funding. The funding round was led by Cathay Innovation, with participation from ZEBOX Ventures. This latest investment brings Nabla’s total funding to over $43 million and will support its mission to revolutionize healthcare delivery through AI-driven solutions.
One of the major challenges faced by healthcare professionals is managing the electronic health record (EHR), which often adds hours of tedious documentation to their workload. Nabla aims to address this pain point by developing an AI-powered solution called Nabla Copilot. This innovative tool leverages proprietary Large Language Models (LLMs) and Speech-to-Text (STT) technologies to streamline clinical documentation and improve efficiency.
Nabla Copilot caters to both small practices and large health systems, offering seamless integration with existing EHR platforms. The solution prioritizes privacy, accuracy, and speed, ensuring cutting-edge performance and security. Since its launch in March 2023, Nabla Copilot has gained significant traction and has already been adopted by more than 20,000 healthcare providers. It has facilitated over 3 million consultations annually, providing accurate notes with a remarkable 95% accuracy rate. This high precision reduces the need for extensive edits and saves clinicians up to 50% of their time on documentation tasks.
The success of Nabla Copilot can be attributed to its accessibility, accuracy, and speed, which address the specific needs of healthcare providers. Nabla’s mission is to empower clinicians and improve patient care by transforming the way healthcare is delivered. By automating and simplifying the process of clinical documentation, Nabla aims to alleviate the burden on healthcare professionals and enable them to focus more on delivering quality care to their patients.
The Series B funding secured by Nabla demonstrates the confidence investors have in the potential of AI-driven solutions in the healthcare industry. The funds will be instrumental in further developing and expanding Nabla’s offering, allowing more healthcare professionals to benefit from its innovative technology.
Nabla’s commitment to advancing the field of healthcare delivery through AI highlights the growing importance of technology in improving patient outcomes. With the continued development and implementation of AI-powered solutions, the healthcare industry is poised for significant transformation. Nabla’s success in securing substantial funding is a testament to its potential to revolutionize healthcare and enhance the overall patient experience.
Frequently Asked Questions (FAQs) Related to the Above News
What is Nabla?
Nabla is a Boston-based artificial intelligence (AI) assistant for healthcare professionals that aims to revolutionize healthcare delivery through AI-driven solutions.
How much funding has Nabla secured in its latest funding round?
Nabla has secured $24 million in Series B funding, bringing its total funding to over $43 million.
Who led the Series B funding round for Nabla?
The funding round was led by Cathay Innovation, with participation from ZEBOX Ventures.
What is the main challenge that Nabla aims to address?
One of the major challenges faced by healthcare professionals is managing the electronic health record (EHR), which often adds hours of tedious documentation to their workload. Nabla aims to address this pain point by developing an AI-powered solution called Nabla Copilot.
What is Nabla Copilot?
Nabla Copilot is an AI-powered solution developed by Nabla that leverages proprietary Large Language Models (LLMs) and Speech-to-Text (STT) technologies to streamline clinical documentation and improve efficiency for healthcare professionals.
Who can benefit from Nabla Copilot?
Nabla Copilot caters to both small practices and large health systems, offering seamless integration with existing EHR platforms.
How accurate is Nabla Copilot?
Nabla Copilot has shown remarkable accuracy, with a 95% accuracy rate in providing accurate notes. This high precision reduces the need for extensive edits, saving clinicians up to 50% of their time on documentation tasks.
What is Nabla's mission?
Nabla's mission is to empower clinicians and improve patient care by transforming the way healthcare is delivered. They aim to automate and simplify the process of clinical documentation to alleviate the burden on healthcare professionals.
How many healthcare providers have already adopted Nabla Copilot?
Since its launch in March 2023, Nabla Copilot has been adopted by more than 20,000 healthcare providers.
What are the key benefits of Nabla's AI-driven solutions?
The key benefits of Nabla's AI-driven solutions include improved efficiency in clinical documentation, reduced burden on healthcare professionals, and increased focus on delivering quality care to patients.
What does Nabla's Series B funding signify?
Nabla's Series B funding demonstrates the confidence investors have in the potential of AI-driven solutions in the healthcare industry. It will support the further development and expansion of Nabla's offering, allowing more healthcare professionals to benefit from its innovative technology.
Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.
